Bone densitometry company Hologic introduced two new digital general radiography systems this month at the RSNA show. Epex and Radex are based on DirectRay solid-state electronic and semiconductor technologies to capture x-rays. Epex is a high-end unit,
Bone densitometry company Hologic introduced two new digital general radiography systems this month at the RSNA show. Epex and Radex are based on DirectRay solid-state electronic and semiconductor technologies to capture x-rays. Epex is a high-end unit, while Radex is a simpler system designed for the outpatient market. Both units will be installed in clinical facilities during the second quarter of 2000.
The two new units round out the Bedford, MA, companys product line, which also includes its DR1000C digital chest system and DR1000 general radiography system. DR1000C units have been installed in five European countries, as well as at sites in Canada and the U.S., and Hologic made its first clinical installations of DR1000 in November.
In other Hologic news, the firm has established a new organizational structure for bringing its systems to market: Hologic will design, market, and service its radiographic products, while its subsidiary, Direct Radiography Corp. (DRC), will be responsible for designing, manufacturing, and servicing DirectRay detectors. DRC will market the detectors as fully integrated Hologic radiographic systems, as a digital image capture upgrade for existing x-ray equipment sold through distributors, and as a component for OEMs.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.